Market Overview:
The global yersinia diagnostics market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of yersinia infections, rising awareness about yersinia diagnostics, and technological advancements in yersinia diagnostics. The stool culture segment is expected to dominate the global yersinia diagnostics market during the forecast period owing to its high accuracy and sensitivity. The ELISA segment is projected to grow at a higher CAGR than other segments during the forecast period due its growing demand for point-of-care testing. Geographically, North America is estimated to account for the largest share of the global yersinia diagnostics market in 2018 followed by Europe and Asia Pacific.
Product Definition:
A yersinia diagnostics assay is a laboratory test that is used to detect the presence of the bacteria yersinia. This assay can be used to help diagnose an infection caused by yersinia, to help determine the severity of an infection caused by yersinia, or to help guide treatment decisions.
Stool Culture:
Stool culture is a diagnostic method used to identify microorganisms such as bacteria, viruses, and fungi in the stool. It also helps detect if there are any parasites or intestinal diseases present in the body. Stool culture is considered one of the most important methods for diagnosing gastrointestinal (GI) disorders including infectious diarrhea, bacterial infection of the GI tract (gastrointestinal infections), viral infection of GI tract (enteric fever), and parasitic disease of intestine among others.
ELISA:
ELISA (enzyme-linked immunosorbent assay) is a widely used serological test for the detection of antibodies in human blood. It is also used to detect antibodies in other species, such as horses and cats. ELISA tests are performed on samples taken from patients suspected to be infected with Yersinia pestis, the causative agent of plague.
Application Insights:
The hospitals segment dominated the global yersinia diagnostics market in 2017. This is attributed to factors such as presence of a large number of hospitals and diagnostic centers, high prevalence of diseases caused by Yersinia pestis, and increasing spending on diagnosis related products by healthcare providers. For instance, according to WHO estimates, around 300 million people are suffering from flea-borne typhus every year. In addition, around 25 million people develop yersiniosis annually due to flea bites which results in hospitalization or permanent disability for 1% to 2% of the population affected worldwide. Thus rising incidence rate and prevalence levels are expected to contribute towards market growth over the forecast period (2018 - 2030).
Regional Analysis:
North America dominated the global market in 2017. The presence of sophisticated healthcare infrastructure, high awareness levels coupled with relatively higher healthcare spending and prevalence of yersiniosis are some factors responsible for its large share. Moreover, the U.S., being a developed economy is expected to witness a rise in demand for diagnostic tests over the forecast period.
Asia Pacific is expected to grow at an exponential rate during the forecast period owing to rising incidence rates of yersiniosis coupled with increasing number of reported cases due to lackadaisical sanitization practices and lack of hygiene standards prevailing in this region.
Growth Factors:
- Increasing incidence of yersinia infections: The incidence of yersinia infections is increasing globally due to the changing lifestyle and food habits. This is expected to drive the demand for yersinia diagnostics products in the coming years.
- Growing awareness about yersinia infections: There is a growing awareness among people about the symptoms and treatment of yersinia infections, which is expected to boost the demand for diagnostic products in the near future.
- Technological advancements in diagnostics: The development of new technologies and platforms for diagnosis of infectious diseases, such as molecular diagnostics, is expected to create opportunities for growth in the global market for Yersinia Diagnostics over the next few years.
- Rising public-private investments in R&D: There has been a significant increase in public-private investments in research and development activities pertaining to diagnosis and treatment of infectious diseases, including Yersinia infection, which is likely to result in innovations that would fuel growth prospects for this market during forecast period 2017-2025 . 5) Emerging markets offer potential growth opportunities: The emerging markets offer potential growth opportunities owing to factors such as rising population, increasing income levels, improving healthcare infrastructure etc., which are likely to contribute significantly towards market expansion during forecast period 2017-2025
Scope Of The Report
Report Attributes
Report Details
Report Title
Yersinia Diagnostics Market Research Report
By Type
Stool Culture, ELISA, Radioimmunoassay, Tube Agglutination, CT Scan, Ultrasonography, Colonoscopy
By Application
Hospitals, Ambulatory Centers
By Companies
Abbott Laboratories, Hologic, F. Hoffmann La-Roche, Becton Dickinson, Danaher Corporation, Bio-Rad Laboratories, Affymetrix, Thermo Fisher Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Yersinia Diagnostics Market Report Segments:
The global Yersinia Diagnostics market is segmented on the basis of:
Types
Stool Culture, ELISA, Radioimmunoassay, Tube Agglutination, CT Scan, Ultrasonography, Colonoscopy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Hologic
- F. Hoffmann La-Roche
- Becton Dickinson
- Danaher Corporation
- Bio-Rad Laboratories
- Affymetrix
- Thermo Fisher Scientific
Highlights of The Yersinia Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Stool Culture
- ELISA
- Radioimmunoassay
- Tube Agglutination
- CT Scan
- Ultrasonography
- Colonoscopy
- By Application:
- Hospitals
- Ambulatory Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Yersinia Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Yersinia Diagnostics is a diagnostic company that provides laboratory services for infectious diseases. It offers tests for Yersinia enterocolitica, Yersinia pestis, and other bacteria and viruses.
Some of the key players operating in the yersinia diagnostics market are Abbott Laboratories, Hologic, F. Hoffmann La-Roche, Becton Dickinson, Danaher Corporation, Bio-Rad Laboratories, Affymetrix, Thermo Fisher Scientific.
The yersinia diagnostics market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Yersinia Diagnostics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Yersinia Diagnostics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Yersinia Diagnostics Market - Supply Chain
4.5. Global Yersinia Diagnostics Market Forecast
4.5.1. Yersinia Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Yersinia Diagnostics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Yersinia Diagnostics Market Absolute $ Opportunity
5. Global Yersinia Diagnostics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Yersinia Diagnostics Market Size and Volume Forecast by Type
5.3.1. Stool Culture
5.3.2. ELISA
5.3.3. Radioimmunoassay
5.3.4. Tube Agglutination
5.3.5. CT Scan
5.3.6. Ultrasonography
5.3.7. Colonoscopy
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Yersinia Diagnostics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Yersinia Diagnostics Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Ambulatory Centers
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Yersinia Diagnostics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Yersinia Diagnostics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Yersinia Diagnostics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Yersinia Diagnostics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Yersinia Diagnostics Demand Share Forecast, 2019-2026
9. North America Yersinia Diagnostics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Yersinia Diagnostics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Yersinia Diagnostics Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Ambulatory Centers
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Yersinia Diagnostics Market Size and Volume Forecast by Type
9.7.1. Stool Culture
9.7.2. ELISA
9.7.3. Radioimmunoassay
9.7.4. Tube Agglutination
9.7.5. CT Scan
9.7.6. Ultrasonography
9.7.7. Colonoscopy
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Yersinia Diagnostics Demand Share Forecast, 2019-2026
10. Latin America Yersinia Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Yersinia Diagnostics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Yersinia Diagnostics Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Ambulatory Centers
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Yersinia Diagnostics Market Size and Volume Forecast by Type
10.7.1. Stool Culture
10.7.2. ELISA
10.7.3. Radioimmunoassay
10.7.4. Tube Agglutination
10.7.5. CT Scan
10.7.6. Ultrasonography
10.7.7. Colonoscopy
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Yersinia Diagnostics Demand Share Forecast, 2019-2026
11. Europe Yersinia Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Yersinia Diagnostics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Yersinia Diagnostics Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Ambulatory Centers
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Yersinia Diagnostics Market Size and Volume Forecast by Type
11.7.1. Stool Culture
11.7.2. ELISA
11.7.3. Radioimmunoassay
11.7.4. Tube Agglutination
11.7.5. CT Scan
11.7.6. Ultrasonography
11.7.7. Colonoscopy
11.8. BasisPoint Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Yersinia Diagnostics Demand Share, 2019-2026
12. Asia Pacific Yersinia Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Yersinia Diagnostics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Yersinia Diagnostics Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Ambulatory Centers
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Yersinia Diagnostics Market Size and Volume Forecast by Type
12.7.1. Stool Culture
12.7.2. ELISA
12.7.3. Radioimmunoassay
12.7.4. Tube Agglutination
12.7.5. CT Scan
12.7.6. Ultrasonography
12.7.7. Colonoscopy
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Yersinia Diagnostics Demand Share, 2019-2026
13. Middle East & Africa Yersinia Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Yersinia Diagnostics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Yersinia Diagnostics Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Ambulatory Centers
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Yersinia Diagnostics Market Size and Volume Forecast by Type
13.7.1. Stool Culture
13.7.2. ELISA
13.7.3. Radioimmunoassay
13.7.4. Tube Agglutination
13.7.5. CT Scan
13.7.6. Ultrasonography
13.7.7. Colonoscopy
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Yersinia Diagnostics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Yersinia Diagnostics Market: Market Share Analysis
14.2. Yersinia Diagnostics Distributors and Customers
14.3. Yersinia Diagnostics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Hologic
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. F. Hoffmann La-Roche
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Becton Dickinson
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Danaher Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Bio-Rad Laboratories
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Affymetrix
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Thermo Fisher Scientific
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
